Welcome to our dedicated page for Greenland Mines news (Ticker: GRML), a resource for investors and traders seeking the latest updates and insights on Greenland Mines stock.
Greenland Mines Ltd. reports developments tied to the Skaergaard Project in East Greenland and to its current two-division structure. Company news commonly covers mineral resource sensitivity work, geological consulting, metallurgical and processing programs, environmental baseline work, Arctic logistics, and Greenland stakeholder engagement.
News also includes corporate updates for Greenland Mines and its subsidiary Major Precious Greenland A/S, including participation in raw-materials and Greenlandic business organizations. The company's disclosures continue to reference its Cell and Gene Therapy division, including Klotho-related programs and KLTO-202 in ALS.
Greenland Mines (Nasdaq: GRML) has commenced its 2026 field season at the Skaergaard Project, with the support vessel Argus departing Reykjavik for southeast Greenland carrying three drill rigs, bulk sampling machinery, geophysical and drone survey equipment, exploration infrastructure, fuel and environmental monitoring tools.
The program deploys a 40+ person specialist team and a multilayered logistics network including Argus as an offshore hub, advance survey vessel MS Byr acquiring seabed and coastal data, and helicopter and fixed‑wing air support via Tasiilaq and the nearby Sodalen airstrip. The 2026 campaign, described by the company as its most comprehensive at Skaergaard, integrates resource drilling, bulk sampling, expanded environmental baseline studies, and geotechnical and engineering work to support an Initial Assessment and evaluation of potential open‑pit and underground mining scenarios.
Greenland Mines (Nasdaq: GRML) announced that Innovation, Science and Economic Development Canada has granted Patent No. CA3,005,398 for a Klotho gene therapy platform licensed from researchers at Universitat Autònoma de Barcelona and collaborators.
The patent covers a nucleic acid sequence encoding secreted Klotho (s-KL), with 42 claims protecting synthesis, gene delivery methods and therapeutic use for multiple neurodegenerative and dementia-related conditions. According to Greenland Mines, KLTO-101, covered by this patent and others in the US, China and Europe, is scheduled to enter process development and manufacturing in August 2026, while KLTO-202 for ALS, multiple sclerosis and other neuromuscular disorders has advanced to GMP manufacturing and is expected to begin regulatory interactions before the end of 2026.
Greenland Mines (Nasdaq: GRML) has adopted a limited-duration stockholder rights plan, effective July 22, 2026, intended to protect all stockholders’ ability to receive full and fair value in any takeover or control transaction. The plan is designed to deter coercive accumulations of a control or blocking stake, including through derivatives, without an appropriate control premium, and to give the board time to evaluate proposals.
According to Greenland Mines, stockholders of record on August 7, 2026 will receive a dividend of one right per common share. The rights generally become exercisable if any person or group acquires 15% or more of outstanding common shares. At that point, holders (other than the acquiring person and related parties) may purchase additional shares at an exercise price of $0.75 per right, with a market value of about twice the exercise price, implying a roughly 50% discount.
The plan, which expires on July 22, 2027 unless earlier redeemed, exchanged or terminated, also provides similar purchase features if, after a person becomes an acquiring person, Greenland Mines is acquired or sells more than 50% of its consolidated assets or earning power. Existing holders at or above 15% before adoption are grandfathered but generally trigger the plan if they increase their stake by 0.20% or more. The board can redeem rights for $0.0001 per right or exchange each right for one common share. Greenland Mines emphasizes the plan does not block offers the board deems fair and beneficial to stockholders.
Greenland Mines (Nasdaq: GRML) announced completion of an S-K 1300-compliant Technical Report Summary for its Skaergaard gold, palladium and platinum project in southeast Greenland, incorporating an updated 2026 Mineral Resource Estimate effective July 3, 2026.
The 2026 MRE shows a 31% increase in Indicated contained PdEq metal to 15.00 Moz and a 24% increase in Inferred contained PdEq to 17.49 Moz versus the 2022 NI 43‑101 estimate. Indicated PdEq grade rises from 2.23 g/t to 3.04 g/t (+36%), while Inferred PdEq grade increases from 2.14 g/t to 3.07 g/t (+44%).
The update uses the same drill database as 2022 but applies higher metal prices (including US$3,500/oz gold), an NSR cut-off of US$84/t and an industry-standard block model, resulting in fewer tonnes but higher grades. The S-K 1300 TRS establishes a U.S. regulatory foundation for Greenland Mines to advance toward an Initial Assessment evaluating open-pit and underground scenarios.
Greenland Mines (Nasdaq: GRML) announced that IP Australia has granted Australian Patent No. 2023252508 for Klotho gene therapy technology exclusively licensed by its Biotech Division. The patent covers human gene therapy using a muscle-cell specific promoter linked to a gene encoding human Klotho s-KL protein to treat motor impairment.
The claims extend to neuronal cells, induced pluripotent stem cells, and delivery systems including adeno-associated viral and non-viral vectors with muscle or motor neuron tropism. According to Greenland Mines, this grant expands its global intellectual property protecting the Klotho-based platform and supports advancement of KLTO-202 toward clinical development in neuromuscular diseases.
Greenland Mines (Nasdaq: GRML) will add Professor Wolfgang Maier and Associate Professor Kristoffer Szilas to its 2026 Skaergaard field campaign in southeast Greenland. Both are established magmatic and Greenland specialists with extensive publication records, research funding and field experience.
Their role is to support geological modeling, improve data quality, integrate the latest academic insights, and help de‑risk future decisions on resource evaluation, mine design concepts and development options at the Skaergaard precious and critical metals project.
Greenland Mines (Nasdaq: GRML) completed a three-day technical workshop to plan the next phase of the Skaergaard Precious and Critical Metals Project in southeast Greenland. Over 15 international experts helped design 2026 drilling, sampling, geophysical, environmental and engineering programs, and a roadmap toward an Initial/Preliminary Economic Assessment and future exploitation licence.
Greenland Mines (Nasdaq: GRML) signed a diamond drilling contract with Nordisk Fundering for the 2026 field campaign at its 80%-owned Skaergaard precious and critical metals project in southeast Greenland.
The roughly 7,500-meter helicopter-supported program will advance resources, metallurgy, geotechnical data, and future open-pit evaluation.
Greenland Mines (Nasdaq: GRML) engaged Tetra Tech and GeoSim to deliver an S‑K 1300‑compliant Mineral Resource Estimate for the Sarfartoq Nd‑Pr rare earth project in southwest Greenland.
The accelerated MRE, targeted for substantial completion by summer 2026, will underpin an updated PEA, integrate historic and Neo‑era drilling, support permitting studies, and strengthen Sarfartoq’s role in Western magnet rare earth supply chains.
Greenland Mines (Nasdaq: GRML) agreed to a strategic share exchange with AnorTech (TSXV: ANOR), gaining an initial 9.9% stake plus a six-month option to increase ownership up to 19.9%.
Greenland Mines will issue 12,400,000 shares for 19,958,503 AnorTech shares, adding exposure to sustainable alumina, HPA, CO2-free cement and midstream critical minerals. Closing is targeted by June 30, 2026, subject to TSXV approval.